Cefonicid price

Cefonicid was compared for the treatment of severe soft tissue infections with cefazolin. awarded after a prospective randomized protocol twice as many patients developed cefonicid, 38 patients were treated with cefonicid and 19 patients with cefazolin. The doses used were 1.0 g once daily, intramuscularly or intravenously for cefonicid and 0.5 to 1.0 g three times per day intramuscularly or intravenously to cefazolin. Clinical diagnosis included cellulitis (39 patients), abscesses (14), infected ulcers (3) and bursitis (1). bacteriological diagnosis only contain Staphylococcus aureus (8 patients), group A streptococcus only (13) associated with S. aureus and streptococci (8), a viridans streptococci only group (1) and mixed anaerobic (1). Gram-negative bacilli were isolated from 11 patients, all in mixed cultures with Gram-positive species. In two patients, Gram-negative organisms were considered causal agent. All 57 patients responded satisfactorily to treatment. Treatment with other medication has not been interrupted or discontinued due to toxicity. Two cefonicid cefazolin and appear to be effective for the treatment of infections of the skin and soft tissue. Cefonicid has the advantage of once-daily administration.